Fig. 1From: Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)Inflammation that relapses and is then retreated leads to accumulative retinal damage and poorer visual outcomes [3]Back to article page